This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Fulgent Genetics, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Ray Yin - Innovator in Pharmaceutical Composition
Introduction
Ray Yin is a notable inventor based in El Monte, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug compositions. His work focuses on enhancing drug solubility and efficacy while minimizing side effects.
Latest Patents
Ray Yin holds a patent for a pharmaceutical composition containing taxane nanoaggregates. This invention is directed to a pharmaceutical composition comprising sodium bicarbonate and a polymer-drug nanoaggregate that includes a polymer and a taxane. The polymer is water-soluble and features terminal groups modified with both hydrophobic and hydrophilic moieties. The taxane can include various compounds such as paclitaxel and docetaxel, which are known for their poor water solubility. This innovative approach aims to improve drug solubility, stability, in vivo availability, and efficacy, while also reducing side effects like renal toxicity. Additionally, the patent outlines a process for producing this pharmaceutical composition and a method for treating diseases, including cancer, using the disclosed composition.
Career Highlights
Ray Yin is currently associated with Fulgent Genetics, Inc., where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on cancer treatment and drug delivery systems.
Collaborations
Ray has collaborated with notable colleagues, including Lin Wang and Bingsen Zhou, to further enhance the scope and application of his inventions.
Conclusion
Ray Yin's innovative contributions to pharmaceutical compositions demonstrate his commitment to improving drug efficacy and safety. His work is paving the way for advancements in cancer treatment and drug delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile